Potassium-competitive acid blockers
Vonoprazan and related acid suppressants.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 27, 28, 30, 37, 46.
New guidelines and consensus this year
- Evidence-based clinical practice guidelines for peptic ulcer disease 2026J Gastroenterol2026 Oct
- Endoscopic diagnosis and management of peptic ulcer bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2026Endoscopy2026 Aug
- [Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised Edition]Korean J Gastroenterol2026 Jul 25
- Consensus Recommendations for the Management of Helicobacter pylori in Egypt: A 2026 ReportDig Dis2026 Jul 7
- Evidence-Based Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea: 2025 Revised EditionHelicobacter2026 Jul-Aug
All papers from the last 12 months
335 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Clinical Utility of Anti-reflux Mucosal Intervention for Refractory Gastroesophageal Reflux Disease in Patients With a Hiatal HerniaDEN Open2027 AprPMID 42677194
- Comparison of Keverprazan-based versus esomeprazole-based dual therapy for initial treatment of Helicobacter pylori infection: a prospective, multicenter, randomized controlled trialAnn Med2026 DecPMID 42572417RCT
- Efficacy and safety of tegoprazan-amoxicillin dual therapy versus bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: a systematic review and meta-analysis of randomized controlled trialsEur J Gastroenterol Hepatol2026 Nov 1PMID 42832287Meta-analysisSystematic review
- Distinct molecular effects of vonoprazan and proton pump inhibitors in eosinophilic esophagitisAllergol Int2026 Oct 14PMID 42875292
- Is Helicobacter pylori Status Responsible for the Altered Pharmacodynamics of Tegoprazan?J Gastroenterol Hepatol2026 Oct 14PMID 42870640
- 14-Day Keverprazan-Amoxicillin Dual Therapy Versus Bismuth-Containing Quadruple Therapy as First-Line Treatment for Helicobacter pylori Eradication: A Prospective, Single-Center, Randomized Controlled TrialJ Gastroenterol Hepatol2026 Oct 13PMID 42869649
- P-CAB - amoxicillin dual therapy for H. pylori eradication: a narrative review of efficacy, safety, and guideline positioningScand J Gastroenterol2026 Oct 10PMID 42856096Review
- Real-world hepatic safety of the potassium-competitive acid blocker: A RUCAM-adjudicated multicenter cohort studyClin Gastroenterol Hepatol2026 Oct 9PMID 42854772
- Beyond gastric acid: pharmacologic modulation of the tumor microenvironment by vonoprazan and its drug-interaction implications for chemotherapy and immunotherapyCancer Chemother Pharmacol2026 Oct 9PMID 42853402Review
- Tegoprazan regulates gut microbiota structure in Helicobacter pylori-induced ulcerative colitis miceFolia Microbiol (Praha)2026 Oct 8PMID 42848254
More gastroenterology trends
All specialties →Endoscopic bariatric therapy
Endoscopic sleeve gastroplasty and other endoscopic weight-loss procedures.
Early-onset colorectal cancer
Colorectal cancer in adults under 50.
Third-space endoscopy
Peroral endoscopic myotomy and endoscopic submucosal dissection.
AI in colonoscopy
Computer-aided polyp detection and characterisation during colonoscopy.
Metallic vs plastic biliary stents
Studies comparing metallic and plastic stents for biliary obstruction.
Blood and stool tests for colorectal cancer screening
Blood-based and multitarget stool tests for colorectal cancer screening.
Key point: Next-generation mt-sDNA and mt-sRNA are preferred 3-year stool options; blood-based tests should be recommended only when preferred screening tests are declined or incomplete.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
vonoprazan[tiab] OR tegoprazan[tiab] OR "potassium-competitive acid blocker*"[tiab]Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.